Focus: Geron is a focused oncology biotech in Foster City, CA, developing small-molecule telomerase inhibitors for blood cancers and solid tumors. The company is mid-stage with a commercial product and an active pipeline spanning multiple indications.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
8 added, 7 removed. Backfill posture.
Best fit for oncology specialists seeking to build deep expertise on a single validated platform with near-term pipeline catalysts, but limited hiring scale and opaque financials present execution risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Geron
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Geron's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
First and only approved telomerase inhibitor; long exclusivity window provides stable commercial foundation for the company.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles